Synopsis
The applicant, a 25-year-old male with a Bachelor of Science degree in mechanical engineering, faced security concerns under Guideline H due to extensive drug involvement and substance misuse. Despite acknowledging his past drug use and expressing a commitment to sobriety, the judge found that the applicant had not sufficiently mitigated the security concerns, particularly regarding his recent use of marijuana and hallucinogenic mushrooms. Consequently, the applicant's request for a security clearance was denied.
Why the Applicant Was Denied
- The applicant had an extensive history of drug involvement, including recent use of marijuana and hallucinogenic mushrooms.
- The applicant's statements of intent to abstain from drug use were not sufficient to mitigate the security concerns due to the recency of his drug use.
- The applicant acknowledged continuing associations with individuals who use illegal drugs shortly before the hearing.
Conditions Referenced
- AG ¶ 25(a)raisedSubstance Misuse
- AG ¶ 25(c)raisedIllegal Possession of a Controlled Substance
- AG ¶ 26(a)rejectedBehavior Happened Long Ago or InfrequentlyThe applicant's recent drug use does not support this condition.
- AG ¶ 26(b)rejectedAcknowledgment of Drug Involvement and Actions Taken to Overcome ItThe applicant's recent drug use and associations with drug users undermine this condition.
Key Rule Quoted
“The illegal use of controlled substances, to include the misuse of prescription and non-prescription drugs, and the use of other substances that cause physical or mental impairment or are used in a manner inconsistent with their intended purpose can raise questions about an individual’s reliability and trustworthiness.”
Procedural Posture
- SOR issuedJan 2, 2025
- Answer filedJan 8, 2025
- Hearing heldSep 9, 2025via video teleconference
- Decision dateMar 25, 2026Decision delayed due to federal government shutdown.
Cite For
- Extensive History of Drug Involvement Under Guideline H
- Recent Drug Use Impacting Security Clearance Eligibility
- Insufficient Mitigation of Drug-related Security Concerns